Companies: 10,795·Total market cap: $144.5T
Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.

ENSCNASDAQHealthcare● Active
$0.25
$-0.00(-0.43%)
Market Cap$2347288
P/E Ratio
52W High$2.75
52W Low$0.23
Overview

Ensysce Biosciences, Inc.(ENSC)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ENSC · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($10176187.00M)($7.99M)($10.63M)($24.21M)($29.15M)
Depreciation & Amort.$6533.00M$0.00M$0.00M$0.00M$0.00M
Stock-Based Comp.$668682.00M$110723.00M$0.88M$1.07M$0.12M
Change in Working Capital$1.52M($0.85M)($0.95M)$5.48M($1.30M)
Net Cash from Operations($7806292.00M)($7502700.00M)($10.78M)($17.89M)($8.24M)
Investing Activities
Capital Expenditure$0.00M$0.00M$0.00M$0.00M$0.00M
Purchases of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Sales of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Net Cash from Investing($123643.00M)$0.00M$0.00M$0.00M$0.00M
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M($290.00M)$0.00M$0.00M$0.00M
Debt Issued / Repaid$0.00M($0.49M)$0.61M$6.13M$13.91M
Net Cash from Financing$8738212.00M$9881173.00M$8.76M$8.77M$20.31M
Free Cash Flow
Free Cash Flow($7806292.00M)($7502700.00M)($10.78M)($17.89M)($8.24M)
FCF Margin %(computed)-483.19%-708.87%-233.41%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Ensysce Biosciences, Inc.

关于Ensysce Biosciences, Inc.(ENSC)现金流量表

Ensysce Biosciences, Inc. 2025财年经营活动现金流($7806.29B),自由现金流($7806.29B)(FCF利润率-154072059.45%),资本支出$0.00B。

常见问题

ENSC · 4 问

Ensysce Biosciences, Inc. 2025财年自由现金流($7806.29B),同比down4.0%。

ENSC free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10